The NM23-H1 gene was overexpressed in various hematologic neoplasms, including AML, acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia in blastic crisis (CML-BC), and myelodysplastic syndrome (MDS), more than in normal blood cells (Figure 1(a)) [10]. Here, NME1 is linked to breast cancer.